IFF and Israel-based foodTech start-up SimpliiGood, by Algaecore Technologies Ltd., partnered to develop a commercial plant-based smoked salmon analog made from whole fresh spirulina.
Image courtesy of SimpliiGood
IFF and Israel-based foodTech start-up SimpliiGood, by Algaecore Technologies Ltd., partnered to develop a commercial plant-based smoked salmon analog made from whole fresh spirulina. The plant-based, salmon-like cuts will take on the appearance, color, texture, and flavor of smoked salmonwithout the ocean pollutants that have become common in fish. The product will also be 40% complete protein.
“Our spirulina can act as a complete replacement for animal-based protein or be easily integrated into existing food products as an added-value ingredient, as it has a neutral flavor and maintains its full nutritional value,” said Lior Shalev, CEO and co-founder of Algaecore, in a press release. “This project marks an exciting milestone in our company’s product line expansion as we enter the fish substitute market.”
In the first phase, the company will focus on producing a pure, spirulina-based smoked salmon analog, with plans to expand to additional fish analogs in the future. An agreement for strategic cooperation was signed among Innovation Authority, SimpliiGood, and FoodNxt. SimpliiGood provides the raw material, texture, and color qualities; IFF contributes the flavor and aroma attributes. The product is expected to hit the market by the end of 2023.
Brightseed launches clinically validated ingredient, Bio Gut Core, to support gut barrier function
May 21st 2025The low-dose, easy-to-formulate ingredient is a proprietary blend of two bioactives – N-trans caffeoyltyramine (NCT) and N-trans feruloyltyramine (NFT) – which were discovered by the company’s Forage AI platform.
A country-by-country blueprint for nutraceutical success in Europe
May 20th 2025The European nutraceutical market is growing rapidly, but the continent is not a monolith when it comes to consumer trends and product innovation. This article is a blue-print for what nutraceutical success looks like in different European countries.